Johnson & Johnson’s (NYSE:JNJ) single-dose Covid-19 vaccine obtained emergency use approval from the U.S. FDA late final week, with a rollout anticipated to start shortly. So what does this imply for J&J’s inventory? General, the vaccine isn’t anticipated to reall www.nasdaq.com
Johnson & Johnson’s (NYSE:JNJ) single-dose Covid-19 vaccine obtained emergency use approval from the U.S. FDA late final week, with a rollout anticipated to start shortly. So what does this imply for J&J’s inventory? General, the vaccine isn’t anticipated to reall
www.nasdaq.com